When calcium goes wrong: Genetic alterations of a ubiquitous signaling route

Nature Genetics

Volumn 34, Issue 2, 2003, Pages 135-141

  Rizzuto, Rosario ^a   Pozzan, Tullio ^b  

^a UNIVERSITY OF FERRARA   (Italy)

^b VENETIAN INSTITUTE OF MOLECULAR MEDICINE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CHANNEL L TYPE; CALCIUM ION;

CALCIUM HOMEOSTASIS; CALCIUM MOBILIZATION; CALCIUM SIGNALING; CHANNEL GATING; GENE MUTATION; GENOTYPE PHENOTYPE CORRELATION; HEART MUSCLE; HUMAN; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; SKELETAL MUSCLE;

CALCIUM CHANNELS; CALCIUM SIGNALING; CALCIUM-TRANSPORTING ATPASES; GENETIC DISEASES, INBORN; HUMANS; MUSCLE, SKELETAL; MUSCULAR DISEASES; MYOCARDIUM; NERVOUS SYSTEM; PHENOTYPE;

EUKARYOTA;

EID: 0037941588     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/ng0603-135     Document Type: Review

References (68)

1. Berridge, M.J., Lipp, P. & Bootman, M.D. The versatility and universality of calcium signaling. Nat. Rev. Mol. Cell Biol. 1, 11-21 (2000).
2. Pozzan, T., Rizzuto, R., Volpe, P. & Meldolesi, J. Molecular and cellular physiology of intracellular calcium stores. Physiol. Rev. 74, 595-636 (1994).
3. Clapham, D.E. Sorting out MIC, TRP, and CRAC ion channels. J. Gen. Physiol. 120, 217-220 (2002).
4. 2+ store, with functional properties distinct from those of the endoplasmic reticulum. EMBO J. 17, 5298-5308 (1998).
5. Schmidt, M. et al. A new phospholipase-C-calcium signaling pathway mediated by cyclic AMP and a Rap GTPase. Nat. Cell Biol. 3, 1020-1024 (2001).
6. Yoo, A.S. et al. Presenilin-mediated modulation of capacitative calcium entry. Neuron 27, 561-572 (2000).
7. Leissring, M.A. et al. Capacitative calcium entry deficits and elevated luminal calcium content in mutant presenilin-1 knockin mice. J. Cell Biol. 149, 793-798 (2000).
8. 2+ influx in Bcl-2-overexpressing cells. J. Cell Biol. 148, 857-862 (2000).
9. 2+ responses. Science 280, 1763-1766 (1998).
10. Jouaville, L.S., Pinton, P., Bastianutto, C., Rutter, G.A. & Rizzuto, R. Regulation of mitochondrial ATP synthesis by calcium: evidence for a long-term metabolic priming. Proc. Natl. Acad. Sci. USA 96, 13807-13812 (1999).
11. 2+ concentration of the endoplasmic reticulum is a key determinant of ceramide-induced apoptosis: significance for the molecular mechanism of Bcl-2 action. EMBO J. 20, 2690-2701 (2001).
12. Panov, A.V. et al. Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines. Nat. Neurosci. 5, 731-736 (2002).
13. Brini, M. et al. A calcium signaling defect in the pathogenesis of a mitochondrial DNA inherited oxidative phosphorylation deficiency. Nat. Med. 5, 951-954 (1999).
14. 2+ ions in excitation-contraction coupling of skeletal muscle fibres. Biochim. Biophys. Acta 1241, 59-116 (1995).
15. Franzini-Armstrong, C. & Protasi, F. Ryanodine receptors of striated muscles: a complex channel capable of multiple interactions. Physiol. Rev. 77, 699-729 (1997).
16. MacLennan, D.H. & Phillips, M.S. Malignant hyperthermia. Science 256, 789-794 (1992).
17. Zhang, Y. et al. A mutation in the human ryanodine receptor gene associated with central core disease. Nat. Genet. 5, 46-50 (1993).
18. Quane, K.A. et al. Detection of a novel mutation at amino acid position 614 in the ryanodine receptor in malignant hyperthermia. Br. J. Anaesth. 79, 332-337 (1997).
19. Fujii, J. et al. Identification of a mutation in porcine ryanodine receptor associated with malignant hyperthermia. Science 253, 448-451 (1991).
20. 2+ regulation defects. Physiol. Rev. 76, 537-592 (1996).
21. 2+ release channels. Am. J. Med. 104, 470-486 (1998).
22. Monnier, N., Procaccio, V., Stieglitz, P. & Lunardi, J. Malignant-hyperthermia susceptibility is associated with a mutation of the α1-subunit of the human dihydropyridine-sensitive L-type voltage-dependent calcium-channel receptor in skeletal muscle. Am. J. Hum. Genet. 60, 1316-1325 (1997).
23. 2+ release channels? Trends Cardiovasc. Med. 12, 189-197 (2002).
24. 2+ signaling and muscle disease. Eur. J. Biochem. 267, 5291-5297 (2000).
25. Turner, P.R., Westwood, T., Regen, C.M. & Steinhardt, R.A. Increased protein degradation results from elevated free calcium levels found in muscle from mdx mice. Nature 335, 735-738 (1988).
26. Robert, V. et al. Alteration in calcium handling at the subcellular level in mdx myotubes. J. Biol. Chem. 276, 4647-4651 (2001).
27. 2+ release channel function and severe central core disease. Proc. Natl. Acad. Sci. USA 96, 4164-4169 (1999).
28. Avila, G., O'Brien, J.J. & Dirksen, R.T. Excitation-contraction uncoupling by a human central core disease mutation in the ryanodine receptor. Proc. Natl. Acad. Sci. USA 98, 4215-4220 (2001).
29. Sternberg, D. et al. Hypokalaemic periodic paralysis type 2 caused by mutations at codon 672 in the muscle sodium channel gene SCN4A. Brain 124, 1091-1099 (2001).
30. Dias Da Silva, M.R., Cerutti, J.M., Arnaldi, L.A. & Maciel, R.M. A mutation in the KCNE3 potassium channel gene is associated with susceptibility to thyrotoxic hypokalemic periodic paralysis. J. Clin. Endocrinol. Metab. 87, 4881-4884 (2002).
31. Rajabally, Y.A. & El Lahawi, M. Hypokalemic periodic paralysis associated with malignant hyperthermia. Muscle Nerve 25, 453-455 (2002).
32. Brody, I.A. Muscle contracture induced by exercise. A syndrome attributable to decreased relaxing factor. N. Engl. J. Med. 281, 187-192 (1969).
33. 2+-adenosine triphosphatase in sarcoplasmic reticulum (Brody's disease). Ann. Neurol. 20, 38-49 (1986).
34. 2+ ATPase, are associated with Brody disease. Nat. Genet. 14, 191-194 (1996).
35. 2+ ATPase (SERCA1) and is associated with Brody disease. Hum. Genet. 106, 482-491 (2000).
36. Tiso, N. et al. Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). Hum. Mol. Genet. 10, 189-194 (2001).
37. Priori, S.G. et al. Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation 103, 196-200 (2001).
38. Tiso, N. et al. The binding of the RyR2 calcium channel to its gating protein FKBP12.6 is oppositely affected by ARVD2 and VTSIP mutations. Biochem. Biophys. Res. Commun. 299, 594-598 (2002).
39. Marx, S.O. et al. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor); defective regulation in failing hearts. Cell 101 365-376 (2000).
40. 2+ channels. Neuroreport 12, 2423-2427 (2001).
41. Brusa, R. et al. Early-onset epilepsy and postnatal lethality associated with an editing-deficient GluR-B allele in mice. Science 270, 1677-1680 (1995).
42. Zuo, J. et al. Neurodegeneration in Lurcher mice caused by mutation in delta2 glutamate receptor gene. Nature 388, 769-773 (1997).
43. Strom, T.M. et al. An L-type calcium-channel gene mutated in incomplete X-linked congenital stationary night blindness. Nat. Genet. 19, 260-263 (1998).
44. Bech-Hansen, N.T. et al. Loss-of-function mutations in a calcium-channel α1-sub-unit gene in Xp11.23 cause incomplete X-linked congenital stationary night blindness. Nat. Genet. 19, 264-267 (1998).
45. Pietrobon, D. Calcium channels and channelopathies of the central nervous system. Mol. Neurobiol. 25, 31-50 (2002).
46. Boycott, K.M. et al. A summary of 20 CACNA1F mutations identified in 36 families with incomplete X-linked congenital stationary night blindness, and characterization of splice variants. Hum. Genet. 108, 91-97 (2001).
47. 2+ channels. Annu. Rev. Cell Dev. Biol. 16, 521-555 (2000).
48. 2+ influx through single human CaV2.1 channels and decrease maximal CaV2.1 current density in neurons. Proc. Natl. Acad. Sci. USA 99, 13284-13289 (2002).
49. Jouvenceau, A. et al. Human epilepsy associated with dysfunction of the brain P/Q-type calcium channel. Lancet 358, 801-807 (2001).
50. Guida, S. et al. Complete loss of P/Q calcium channel activity caused by a CACNAIA missense mutation carried by patients with episodic ataxia type 2. Am. J. Hum. Genet. 68, 759-764 (2001).
51. 2+ channel Cav2.1 missense mutations associated with episodic ataxia type 2 and progressive ataxia. J. Biol. Chem. 277, 6960-6966 (2002).
52. Margolis, R.L. The spinocerebellar ataxias: order emerges from chaos. Curr. Neurol. Neurosci. Rep. 2, 447-456 (2002).
53. Toru, S. et al. Spinocerebellar ataxia type 6 mutation alters P-type calcium channel function. J. Biol. Chem. 275, 10893-10898 (2000).
54. 2+ channel currents arising from expanded trinucleotide-repeats in spinocerebellar ataxia type 6. J. Neurosci. 21, 9185-9193 (2001).
55. 2+ pump, cause Darier disease. Nat. Genet. 21, 271-277 (1999).
56. Hu, Z. et al. Mutations in ATP2C1, encoding a calcium pump, cause Hailey-Hailey disease. Nat. Genet. 24, 61-65 (2000).
57. 2+ pump. Hum. Mol. Genet. 9, 1131-1140 (2000).
58. 2+-ATPase function is required for intracellular trafficking of the Notch receptor in Drosophila. EMBO J. 18, 5983-5993 (1999).
59. Egan, M.E. et al. Calcium-pump inhibitors induce functional surface expression of Delta F508-CFTR protein in cystic fibrosis epithelial cells. Nat. Med. 8, 485-492 (2002).
60. Mesaeli, N. et al. Calreticulin is essential for cardiac development. J. Cell Biol. 144, 857-868 (1999).
61. 2+/calcineurin and NFATc3/C4 pattern the developing vasculature. Cell 105, 863-875 (2001).
62. Koulen, P. et al. Polycystin-2 is an intracellular calcium release channel. Nat. Cell Biol. 4, 191-197 (2002).
63. Walder, R.Y. et al. Mutation of TRPM6 causes familial hypomagnesemia with secondary hypocalcemia. Nat. Genet. 31, 171-174 (2002).
64. Schlingmann, K.P. et al. Hypomagnesemia with secondary hypocalcemia is caused by mutations in TRPM6, a new member of the TRPM gene family. Nat. Genet. 31, 166-170 (2002).
65. Futatsugi, A. et al. Facilitation of NMDAR-independent LTP and spatial learning in mutant mice lacking ryanodine receptor type 3. Neuron 24, 701-713 (1999).
66. Balschun, D. et al. Deletion of the ryanodine receptor type 3 (RyR3) impairs forms of synaptic plasticity and spatial learning. EMBO J. 18, 5264-5273 (1999).
67. 2+ channels. Annu. Rev. Cell Dev. Biol. 16, 521-555 (2000).
68. Ertel, E.A. et al. Nomenclature of voltage-gated calcium channels. Neuron 25, 533-535 (2000).